Co-Diagnostics, Inc. (CODX) Gross margin 2017–2025
Co-Diagnostics, Inc. (CODX) gross margin by fiscal year — reported gross profit divided by reported revenue.
64.3%FY2025 · since FY2017: 96.1% → 64.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 64.3% | -10.2 pp |
| FY2024 | 74.5% | +35.9 pp |
| FY2023 | 38.6% | -45.4 pp |
| FY2022 | 84.0% | -4.2 pp |
| FY2021 | 88.2% | +10.4 pp |
| FY2020 | 77.7% | +30.0 pp |
| FY2019 | 47.7% | -28.8 pp |
| FY2018 | 76.5% | -19.6 pp |
| FY2017 | 96.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice